Entropy Technologies LP Has $7.35 Million Holdings in Ventas, Inc. $VTR

Entropy Technologies LP increased its stake in shares of Ventas, Inc. (NYSE:VTR) by 30.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 104,997 shares of the real estate investment trust’s stock after acquiring an additional 24,801 shares during the period. Entropy Technologies LP’s holdings in Ventas were worth $7,349,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Quantitative Investment Management LLC bought a new position in shares of Ventas in the third quarter valued at $2,173,000. Arrowstreet Capital Limited Partnership raised its position in Ventas by 145.4% during the third quarter. Arrowstreet Capital Limited Partnership now owns 296,355 shares of the real estate investment trust’s stock worth $20,742,000 after acquiring an additional 175,576 shares in the last quarter. Invesco Ltd. lifted its stake in Ventas by 21.5% in the third quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock valued at $409,274,000 after acquiring an additional 1,034,634 shares during the last quarter. Cbre Investment Management Listed Real Assets LLC grew its position in shares of Ventas by 93.5% in the 3rd quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,750,598 shares of the real estate investment trust’s stock valued at $122,524,000 after acquiring an additional 845,694 shares during the period. Finally, Elevatus Welath Management bought a new position in shares of Ventas in the 3rd quarter valued at about $2,767,000. 94.18% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the transaction, the chief executive officer owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 86,106 shares of company stock valued at $6,931,397. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

VTR has been the topic of a number of research analyst reports. KeyCorp upped their target price on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Wells Fargo & Company lifted their price target on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Citigroup boosted their price target on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Royal Bank Of Canada upped their price objective on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Stock Performance

Shares of VTR stock opened at $86.14 on Friday. Ventas, Inc. has a 52 week low of $60.15 and a 52 week high of $87.87. The company has a market capitalization of $40.91 billion, a price-to-earnings ratio of 159.51, a PEG ratio of 2.09 and a beta of 0.73. The company has a 50-day simple moving average of $81.27 and a 200 day simple moving average of $76.19. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last released its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The company had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is 355.56%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.